Site icon OncologyTube

Developing Personalized Medicine for PARP Inhibitor Therapy

Elizabeth Swisher, MD of University of Washington Medical Center discusses development of more efficient clinical tests that will accurately predict which patients respond to PARP inhibitors. This was recorded at the 2017 Society of Gynecologic Oncology (SGO)s Annual Meeting on Womens CancerĀ® in National Harbor, MD.

Exit mobile version